This federal contract award to Cerilliant Corporation, a foreign-owned manufacturer based in Round Rock, Texas, is for the supply of drug standards used for screening and confirmation testing of urine, blood, and tissue samples from service members suspected of drug use. The $10,010.88 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), a defense agency. Cerilliant, which has over 30 years of experience as a government contractor, will...
This is a federal contract award to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference materials based in Round Rock, Texas. The contract, awarded by the Defense Health Agency (DHA), is for the provision of medical supplies. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type and a ceiling value of $32,348.38. The contract is set to expire on September 30, 2023. Cerilliant Corporation has a history of...
This federal contract award to Cerilliant Corporation is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), valued at $15,522.70. The contract is for the provision of drug reference standards and calibration materials to support drug testing and screening of service member specimens, including post-mortem urine, blood, and tissue samples. The contract has a completion date of August 15, 2024 and is a firm fixed price arrangement. Cerilliant Corporation is a global...
This federal contract award is a Blanket Purchase Agreement (BPA) call issued by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials and laboratory supplies. The contract, valued at $8,279.36, is for the provision of drug reference standards to support the DHA's drug screening and testing programs for service members. Cerilliant Corporation is a foreign-owned, for-profit manufacturer based in Texas, with over 30 years of experience as a...
This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Cerilliant Corporation, a global manufacturer of certified reference materials and analytical standards. The contract, valued at $22,803.21, is for the provision of drug screening and confirmation testing services for suspected drug use in service member investigative and/or post-mortem urine, blood, and tissue samples. The contract has an ultimate completion date of September 30, 2025. Cerilliant Corporation, a...
Cerilliant Corporation was awarded a $13,064.06 firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency to provide laboratory supplies. The contract has no set-aside designation and runs from the May 19, 2023 award date through the May 19, 2023 completion date. Cerilliant will deliver the requested chemical and biological reference standards and calibrators to support the agency's laboratory programs from their place of performance in Fort Meade, Maryland. No...
Cerilliant Corporation was awarded a firm fixed price call against the Blanket Purchase Agreement with the Defense Health Agency with a potential value of $19,158.95. The contract is for the provision of reference standards, reagents, calibrators and other laboratory materials to support testing and healthcare programs at Fort Meade, Maryland. No set aside designation was applied. Cerilliant is a global leader in supplying chemical and biological reference standards to federal agencies. They...
Cerilliant Corporation was awarded a $19,723.40 firm fixed price blanket purchase agreement call from the Defense Health Agency to provide drug supplies. As a global leader in certified reference standards for over 30 years, Cerilliant will deliver chemical reference materials from its Round Rock, Texas headquarters to support agency testing and healthcare programs at the place of performance in Fort Meade, Maryland. Cerilliant currently holds several indefinite delivery/indefinite quantity...
This is a BPA (Blanket Purchase Agreement) call awarded by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials. The contract, valued at $11,104.95, is for the supply of FTDTL (Forensic Toxicology Drug Testing Laboratory) Cerilliant supplies for the Fort Meade location. This BPA call is part of a larger $250,000 DHA BPA that Cerilliant holds to provide drug reference standards through September 2028. Cerilliant, a foreign-owned, for-profit...
Cerilliant Corporation was awarded a firm fixed price call against the Defense Health Agency's blanket purchase agreement for the provision of $5,881.55 worth of reagent and laboratory supplies. As a global leader in reference standards and with over 30 years of experience supplying partners, Cerilliant will deliver certified chemical and biological reference materials to support testing and healthcare programs at the Defense Health Agency located in Fort Meade, Maryland. Cerilliant primarily...